![Inside a CRO: Essential Insights from Medical Monitoring](https://www.precisionformedicine.com/hs-fs/hubfs/PFM%20-%202024%20New%20blog%20images/Essential%20Medical%20Monitoring.webp?width=396&height=224&name=Essential%20Medical%20Monitoring.webp)
![Etleva, Pashaj Avatar](https://www.precisionformedicine.com/hs-fs/hubfs/PfM%20Website/Headshots/Headshots%20no%20background/Etleva-Pashaj.png?width=100&height=100&name=Etleva-Pashaj.png)
Etleva Pashaj
Etleva Pashaj, MD is a strategic, innovation-driven, drug discovery veteran—as well as a board-certified oncologist—with extensive international (EMA and FDA) regulatory experience. She has a record of excellence in clinical development, medical monitoring and medical strategy, and managing and mentoring cross-functional and global teams for phase 1-4 onco-hematology studies.
-
Read: Inside a CRO: Essential Insights from Medical Monitoring Inside a CRO: Essential Insights from Medical Monitoring
-
Read: Optimizing Inclusion and Exclusion Criteria in Early Phase Oncology Clinical Trials Clinical Trials - Early Phase Research - Oncology
Optimizing Inclusion and Exclusion Criteria in Early Phase Oncology Clinical Trials
|
Loading...
You've reach the end